GALIMBERTI, FEDERICA
GALIMBERTI, FEDERICA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group
2022 C. Pederiva, M.E. Capra, G. Biasucci, G. Banderali, E. Fabrizi, M. Gazzotti, M. Casula, A.L. Catapano, M. Arca, M. Averna, S. Bertolini, S. Calandra, P. Tarugi, F. Pellegatta, A. Marcello, A. Maurizio, B. Andrea, B. Giacomo, B. Claudio, C. Paolo, C. Francesca, C. Francesco, C. Nadia, Maria Del Ben, F. Giuliana, G. Ornella, I. Arcangelo, I. Gabriella, I. Lorenzo, M. Giuseppe, M. Lorenzo, G.G. Mombelli, M. Sandro, P. Gianfranco, P. Angelina, C.A. Pederiva, P. Livia, P. Arturo, P. Francesco, Anna Rita Roscini, S. Riccardo, S. Patrizia, Josè Pablo Werba, Z. Sabina, Maria Grazia Zenti, A. Massimiliano, A. Renata, B. Davide, B. Giuseppe, B. Patrizia, B. Marco, Paola Sabrina Buonuomo, Angelo Baldassarre Cefalù, C. Giuseppe, D. Sergio, Maria Donata Di Taranto, F. Roberto, F. Fabio, G. Simonetta, G. Liliana, L. Graziana, M. Sara, G. Massini, M. Ilenia, M. Tiziana, N. Fabio, C. Pavanello, Francesco Massimo Perla, P. Gaia, S. Elena, S. Roberto, T. Arianna, Giovanni Battista Vigna, Z. Alberto, M. Casula, F. Galimberti, M. Gazzotti, E. Olmastroni, V. Zampoleri
Potentially Inappropriate Prescribing among Elderly Outpatients: Evaluation of Temporal Trends 2012–2018 in Piedmont, Italy
2022 F. Galimberti, M. Casula, L. Scotti, E. Olmastroni, D. Ferrante, A. Ucciero, E. Tragni, A.L. Catapano, F. Barone-Adesi
Statin use and risk of dementia or Alzheimer's disease : a systematic review and meta-analysis of observational studies
2022 E. Olmastroni, G. Molari, N. De Beni, O. Colpani, F. Galimberti, M. Gazzotti, A. Zambon, A.L. Catapano, M. Casula
Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials
2020 M. Casula, E. Olmastroni, M. Gazzotti, F. Galimberti, A. Zambon, A.L. Catapano
Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study
2020 M. Casula, E. Olmastroni, F. Galimberti, E. Tragni, G. Corrao, L. Scotti, A.L. Catapano
A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: Design and rationale of the EDU.RE.DRUG study
2020 M. Casula, E. Menditto, F. Galimberti, V. Russo, E. Olmastroni, L. Scotti, V. Orlando, G. Corrao, A.L. Catapano, E. Tragni
Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study
2020 V. Russo, V. Orlando, V.M. Monetti, F. Galimberti, M. Casula, E. Olmastroni, E. Tragni, E. Menditto
STRATEGIES TO ASSESS AND PROMOTE APPROPRIATE DRUG PRESCRIBING AND USE AMONG ADULT OUTPATIENTS IN CAMPANIA AND LOMBARDY REGIONS
2019 F. Galimberti
EFSA new guidance on endocrine disruptors: comments, critical aspects and a case study
2018 F. Metruccio, F. Galimberti, C. Civitella, V. Guercio, A. Moretto
Use of proton pump inhibitors and risk of ischemic events in the general population
2018 M. Casula, L. Scotti, F. Galimberti, F. Mozzanica, E. Tragni, G. Corrao, A.L. Catapano